VANCE trial marks milestone in t cell therapy for solid tumors

The largest ever clinical trial of T cell therapy for solid tumors has ended, heralding a new era for precision T cell therapy.

Eating Disorders After GLP-1s? Tirzepatide for Heart Failure; Soda Taxes and BMI

Weight-loss drugs like tirzepatide (Zepbound) and semaglutide (Wegovy) may trigger eating disorders in certain patients, doctors warned. (NBC News) In a placebo-controlled phase III trial,

August 7, 2024

Advances and hurdles: The impact of AI on oncology care efficiency and mortality rates

The benefits and limitations of precision medicine techniques in oncology research and treatment.

April 3, 2024

Next-generation sequencing provides novel insights into the mechanisms underlying autism and myotonic muscular dystrophy

The pathomechanistic connection between autism and myotonic muscular dystrophy type 1.

August 16, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.